About Careers MedBlog Contact us

New Molecular Target for Treating Neuropsychiatric Disorders

by Anjali Aryamvally on February 4, 2018 at 7:28 PM
Font : A-A+

New Molecular Target for Treating Neuropsychiatric Disorders

A molecule that aids the process of discarding weak and unwanted neural circuits in the brain, if malfunctioning, could lead to disorders such as autism and dementia, according to a study from Japan.

As the brain develops in utero and in early life, neurons and their connecting synapses branch out rapidly - like a tree. Over time, these connections become more refined and purposeful via a series of molecular mechanisms that prune the connections. Like a gardener trims a tree, weaker branches are discarded to redirect nutrients to help nurture the stronger branches.


However, genetic and environmental mutations can misguide this process and eliminate far too many synapses or not nearly enough. Either extreme can result in a myriad of neuropsychiatric disorders from autism spectrum disorder to schizophrenia to dementia.

The research team was led by Masanobu Kano, professor in the Department of Neurophysiology at the Graduate School of Medicine at the University of Tokyo.

The authors published their results in the journal Neuron.

In a typically developing brain, a type of neuron called a Purkinje cell is furnished with climbing fibers. "Among multiple climbing fibers innervating each Purkinje cell in the neonatal cerebellum, a single climbing fiber is strengthened and maintained throughout an animal's life, whereas the other climbing fibers are weakened and eventually eliminated," Kano says. "Our goal was to identify a new molecule involved in strengthening and maintaining single climbing fiber inputs."

Kano and his team found that progranulin - a protein known to be involved in certain forms of dementia - also works to maintain developing climbing fiber inputs, counteracting the initial elimination. They studied a mouse model engineered without progranulin and found that climbing fibers were more quickly eliminated and climbing fiber input overall was significantly reduced.

"Our results provide a new insight into the roles of progranulin in the developing brain," says Kano. "We will continue to search molecules involved in synapse elimination in the developing cerebellum and, ultimately, we want to elucidate entire signaling cascades for synapse elimination."

Although the researchers do not yet know how to effectively manipulate the molecule, it's possible that progranulin signaling may be a potential therapeutic target for neuropsychiatric disorders.

Source: Eurekalert


Recommended Reading

Latest Research News

Nearsightedness: Atropine Eye Drops may Slow Progression in Kids
A recent clinical trial suggests that the first medication therapy to reduce the progression of nearsightedness in children could be on the way.
Autoimmune Diseases Affect One in Ten: Study
Autoimmune disorders were found to be linked to Sjogren's, systemic lupus erythematosus, and systemic sclerosis.
Remarkable Journey of Transforming Lives With Brain Pacemaker
Successful brain pacemaker implantation has helped a 51year old Parkinson's disease patient to revitalize her quality of life.
What Are the Effects of Healthy Lifestyle on Osteoarthritis?
Recent recommendations on lifestyle behaviors to prevent progression of rheumatic and musculoskeletal diseases revealed.
Unraveling the Mystery of Psoriasis Severity
The study offers insights into how psoriasis can trigger diabetes, heart disease, and inflammatory bowel disease.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

New Molecular Target for Treating Neuropsychiatric Disorders Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests